Skip to main content
. 2021 Apr 2;15(4):1089–1098. doi: 10.1007/s12105-021-01318-4

Table 4.

Morphologic types and features by high risk HPV 16 lineage

A B C D p value*
All patients 191 1 4 16
Histologic type
  Conventional
    Nonkeratinizing 116 (60.7) 0 1 (25.0) 11 (64.7) 0.57
    Nonkeratinizing with maturation 44 (23.0) 1 2 (50.0) 3 (18.8) 0.33
    Keratinizing 7 (3.7) 0 0 0 0.36
Subtypes
  Adenosquamous (Including Ciliated) 6 (3.1) 0 0 0.89
  Lymphoepithelial 6 (3.1) 0 1 (25.0) 0
  Basaloid 2 (1.0) 0 0 1 (5.9)
  Papillary 10 (5.2) 0 0 1 (5.9)
Anaplasia present? 48 (25.1) 0 1 (25.0) 1 (5.9) 0.09
Multinucleation present? 76 (39.8) 0 2 (50.0) 5 (29.4) 0.47
Anaplasia and/or Multinucleation present? 89 (46.6) 0 3 (75.0) 7 (41.2) 0.92
Multinucleation index (MNI) (Average)
  MNI 1 or more 104 (54.5) 0 4 (100.0) 9 (52.9) 0.76
  MNI 3 or more 81 (42.4) 0 2 (50.0) 5 (29.4) 0.30
  MNI 11 or more 28 (14.7) 0 2 (50.0) 1 (5.9) 0.87
Stromal desmoplasia (%) (Average)
  1% or more 115 (60.2) 1 3 75.0) 10 (58.8) 0.76
  11% or more 46 (24.1) 1 1 (25.0) 3 (17.6) 0.89
  31% or more 9 (4.7) 0 1 (25.0) 0 0.97
Maturing squamous differentiation (%) (Average)
  1% or more 141 (73.8) 1 3 (75.0) 12 (70.6) 0.91
  11% or more 54 (28.3) 1 2 (50.0) 5 (29.4) 0.43
  31% or more 28 (14.7) 1 0 3 (17.6) 0.32
  51% or more 17 (8.9) 1 0 2 (11.8) 0.47

*Value for HPV 16 subtype A vs other subtypes